Keratolytic Agents
Research News and Information

Monday, November 23, 2009

No indications for HPV involvement in the hypertrophic skin lesions of a Darier disease case without ATP2A2 gene mutations.

30 Aug 2009 Darier disease (DD) is a relatively common genodermatosis characterized by impaired differentiation and abnormal cell-to-cell adhesion. Haploinsufficiency of the ATP2A2 gene product, sarco/endoplasmic reticulum Ca(2+) ATPase isoform 2 (SERCA2), is ... Read more...

Benefits of using a hydroquinone/tretinoin skin care system in patients undergoing intense pulsed light therapy for photorejuvenation: a placebo-controlled study.

30 Aug 2009 A hydroquinone/tretinoin (HQ/tret) skin care system designed for use with non-surgical facial rejuvenation procedures has recently become available. In this observer-masked study, 36 patients with moderate-to-severe wrinkling of the skin around the ... Read more...

A possible contribution of retinoids to regulation of fetal B lymphopoiesis.

30 Aug 2009 We recently found that all trans retinoic acid (ATRA) accelerated B lymphocyte formation. In the current study, we address the question whether retinoids account for the rapid lymphopoiesis that is characteristic of fetal progenitors. Surprisingly, ... Read more...

Latest indexed articles for 'Keratolytic Agents'

These are the very latest articles for this heading:

• Comments on study of paw pad lesions in dogs. 13 Sep 2009
• Sequential systemic retinoid and photodynamic therapy for multiple keratotic pigmented nodular basal cell carcinomas on the scalp. 30 Aug 2009
• No indications for HPV involvement in the hypertrophic skin lesions of a Darier disease case without ATP2A2 gene mutations. 30 Aug 2009
• Benefits of using a hydroquinone/tretinoin skin care system in patients undergoing intense pulsed light therapy for photorejuvenation: a placebo-controlled study. 30 Aug 2009
• A possible contribution of retinoids to regulation of fetal B lymphopoiesis. 30 Aug 2009
• Repigmentation and curling of hair after acitretin therapy. 30 Jul 2009
• 5-Fluorouracil superficial peel for multiple actinic keratoses. 30 Jul 2009
• Retinoids and phototherapy for psoriasis. 30 Jul 2009
• Traditional systemic treatment of psoriasis. 30 Jul 2009
• Retinoid-responsive transcriptional changes in epidermal keratinocytes. 30 Jul 2009
• Effect of slow-releasing all-trans-retinoic acid in bioabsorbable polymer on delayed adjustable strabismus surgery in a rabbit model. 7 Jul 2009
• Palmoplantar pustulosis with arthro-osteitis: successful treatment with etanercept and acitretin. 29 Jun 2009
• Ichthyosis follicularis, alopecia, and photophobia (IFAP) syndrome due to mutation of the gene MBTPS2 in a large Australian kindred. 29 Jun 2009
• Why is it so hard to get rid of plantar warts? 29 Jun 2009
• A 3-step acne system containing solubilized benzoyl peroxide versus clindamycin-benzoyl peroxide. 29 Jun 2009
• The management of condyloma acuminata in the pediatric population. 29 Jun 2009
• A fully validated HPLC method for the simultaneous determination of acitretin and etretinate in plasma and its application to a pharmacokinetic study in healthy Korean subjects. 29 Jun 2009
• Tretinoin microsphere gel pump 0.04% versus tazarotene cream 0.05% in the treatment of mild-to-moderate facial acne vulgaris. 29 Jun 2009
• Comparative efficacy and safety results of two topical combination acne regimens. 29 Jun 2009
• Retinoic acid inhibits dendritic cell differentiation driven by interleukin-4. 4 Jun 2009

See a longer list of these articles.

Technical information about 'Keratolytic Agents'

Definition: Agents that soften, separate, and cause desquamation of the cornified epithelium or horny layer of skin. They are used to expose mycelia of infecting fungi or to treat corns, warts, and certain other skin diseases.

Registry Number: 0

Descriptor UI: D007641

Alternative terms: Keratolytic Agents; Agents, Keratolytic; Skin-Peeling Agents; Agents, Skin-Peeling; Skin Peeling Agents; Desquamating Agents; Agents, Desquamating;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D27.505.954.444.400;

Online Note: search DERMATOLOGIC AGENTS 1967-74

History Note: 91(75); was see under DERMATOLOGIC AGENTS 1975-90

Technical Notes: GEN or unspecified; prefer specifics